Thursday, April 6, 2023 episode artwork

EPISODE · Apr 6, 2023 · 7 MIN

Thursday, April 6, 2023

from The Gist Healthcare Podcast

The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Thursday, April 6, 2023

0:00 7:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 7 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on April 6, 2023.

What is this episode about?

The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!